A newly emerging class of biomolecules – glycosylated RNA, or “glycoRNA” – is continuing to rewrite the rules of cell biology. For decades, glycosylation was understood mainly as a modification of proteins and lipids. But recent work has shown that glycans can also be attached to RNA, creating molecules that appear to participate in processes ranging from immune regulation to intercellular communication. A new review now brings together the fast-growing analytical toolbox needed to study them, with a particular focus on mass spectrometry.
The review surveys the full MS-based workflow for glycoRNA analysis, from sample collection and total RNA extraction through enrichment, glycan release, purification, optional derivatization, and final LC-MS/MS analysis. Because glycoRNA is typically short, rare, and easily confounded by contaminating glycoproteins, the authors pay particular attention to sample handling and enrichment strategies. These include metabolic labeling approaches such as Ac4GalNAz, as well as chemoenzymatic and oxidation-based methods including StCEL and rPAL, which enable selective capture of glycoRNA from complex biological material.
Once enriched, glycoRNA-derived glycans can be released and characterized using separation methods such as porous graphitized carbon, HILIC, and reversed-phase LC, paired with multiple MS fragmentation modes including CID, HCD, and ETD. The review also highlights the growing importance of computational tools such as GlycoNote, GlycanDIA Finder, and GlyTrait, which are helping researchers move beyond simple glycan detection toward more confident structural interpretation and biological comparison across samples.
Importantly, the review does more than catalog methods. It also underscores the biological significance of glycoRNA profiling. Across different cell types and tissues, glycoRNA appears to carry distinct glycan signatures, with particularly strong signals for fucosylated and sialylated structures. Such patterns may eventually prove useful as biomarkers for disease diagnosis and prognosis, especially as glycoRNA studies expand into tissues, extracellular vesicles, and clinical samples.
Challenges remain, particularly around low abundance, contamination control, and the lack of bioinformatics platforms tailored specifically to glycoRNA. Even so, the field is moving quickly. By laying out an integrated methodological framework, this review positions mass spectrometry-based glycomics as a key driver in turning glycoRNA from an intriguing discovery into a tractable target for biomedical research and, potentially, precision medicine.
Newsletters
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
